Home › Stocks › LABT

LABT — LAKEWOOD-AMEDEX BIOTHERAPEUT

Reported value held$313.76K
Funds holding (latest)11
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)10
Institutional value$173.76K · 181.89K sh
New / Add / Cut / Exit5 / 3 / 0 / 1 · Updated 2026-11-17
Top-5 / Top-10 concentration94.0% / 100.0%
Institutional holdings change Accumulating +51.2% (+27.13K sh)
Institutional value change Down -54.0%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Wall Street Analyst Consensus

Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19

Consensus ratingStrong Buy
Analysts covering—
12-month price target$7.50 (+3173.7%)
Last price at fetch$0.23
Forward P/E (FY1)0.1×
Forward P/E (FY2)1.4×
Revision score (quarter)+0.00
Revision score (year)+0.00
Consensus EPS vs implied forward P/E by fiscal year
62×41×31×10×00×EPS (USD)Forward P/E4.960.160.0×1.4×FY26FY27
Fiscal quarter end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 -0.34 — 0.76 -1.44 2 —
Fiscal year end Consensus EPS forecast Forward P/E High EPS Low EPS # estimates Revisions (4wk up/down)
Dec 2026 4.96 0.0× 4.96 4.96 1 —
Dec 2027 0.16 1.4× 1.32 -1.01 2 —
Dec 2028 -0.06 — 1.16 -1.29 2 —
Dec 2029 -1.59 — -1.59 -1.59 1 —

Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 10 SEC-registered investment managers reported holding LABT (LAKEWOOD-AMEDEX BIOTHERAPEUT) in their latest 13F filings, with a combined reported value of $173.76K across 181.89K shares. That is +51.2% by share count (+27.13K shares) versus the previous quarter, while reported value moved -54.0%. Ownership is concentrated: the five largest holders account for 94.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 5 opened new positions, 3 added to existing stakes, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) include HRT FINANCIAL LP, Marex Group Ltd, Geode Capital Management, ranked by reported 13F value among the 11 institutional holders on this page.

LABT is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 10 181.89K $173.76K +51.2%
Q2 2026 6 97.82K $306.54K —

Over the 2 quarters shown, institutional share counts increased 86% in aggregate (Q2 2026 → Q3 2026).

Top Institutional Holders (Q3 2026) — 10 funds

FundSharesValuePortfolio WeightChange
Marex Group Ltd 72.42K $69.18K 0.00% Add
Geode Capital Management 44.80K $42.80K 0.00% New
STATE STREET CORP 24.00K $22.93K 0.00% New
Citadel Advisors 19.01K $18.16K 0.00% New
Citigroup Inc 10.73K $10.25K 0.00% New
UBS Group AG 4.60K $4.40K 0.00% Add
Westend Capital Management, LLC 3.18K $3.04K 0.00% New
Tower Research Capital LLC (TRC) 3.00K $2.87K 0.00% Add
OSAIC HOLDINGS, INC. 138 $132 0.00% Hold
Blue Trust, Inc. 11 $11 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 6 funds

FundSharesValuePortfolio WeightChange
Marex Group Ltd 48.17K $151.24K 0.00% New
HRT FINANCIAL LP 44.78K $140.00K 0.00% New
UBS Group AG 4.10K $12.87K 0.00% New
Tower Research Capital LLC (TRC) 624 $1.96K 0.00% New
OSAIC HOLDINGS, INC. 138 $433 0.00% New
Blue Trust, Inc. 11 $35 0.00% New

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 11 funds)

FundQ3 2026Q2 2026
Marex Group Ltd 72.42K 48.17K
Geode Capital Management 44.80K —
STATE STREET CORP 24.00K —
Citadel Advisors 19.01K —
Citigroup Inc 10.73K —
UBS Group AG 4.60K 4.10K
Westend Capital Management, LLC 3.18K —
Tower Research Capital LLC (TRC) 3.00K 624
OSAIC HOLDINGS, INC. 138 138
Blue Trust, Inc. 11 11
HRT FINANCIAL LP — 44.78K

Download holders (CSV)

FAQ

Which funds hold LABT?

As of 2026-Q3, 10 institutional funds reported holding LABT (LAKEWOOD-AMEDEX BIOTHERAPEUT) in SEC 13F filings, with a combined reported value of $173.76K.

How many shares of LABT do institutions own?

13F filers reported 181.89K shares of LABT, worth $173.76K in aggregate at the end of 2026-Q3.

Is institutional ownership of LABT rising or falling?

Share counts moved +51.2% versus the prior quarter — accumulation.

Who are the top institutional holders of LABT?

The largest 13F holders are HRT FINANCIAL LP, Marex Group Ltd, Geode Capital Management, STATE STREET CORP, Citadel Advisors; the top 25 are ranked at the top of this page.

Who are the major shareholders of LAKEWOOD-AMEDEX BIOTHERAPEUT?

The major shareholders of LAKEWOOD-AMEDEX BIOTHERAPEUT (LABT) by reported 13F value are HRT FINANCIAL LP, Marex Group Ltd, Geode Capital Management, STATE STREET CORP, Citadel Advisors, among 11 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own LABT" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/LABT/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →